Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Lab pricing varies by network
It is an investigational triple agonist , targeting GLP-1, GIP, and glucagon receptors simultaneously
The intracerebroventricular (ICV) injection of the DEETGE-Cal-Tat peptide showed an increased expression of Nrf2- regulated genes and marked neuroprotective and cognitive-preserving effects in mice subjected to brain injury [301]
Its always encouraged to consult with your doctors for the latest information and recommendations specific to your situation
Food and Drug Administration (FDA) has announced that the shortage of tirzepatide (Mounjaro/Zepbound) has been resolved, marking a significant development in the ongoing GLP-1 medication supply challenges
B.Garrido-MartnezM.et al (2019)
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
